MEGAN MENDOZA: Open Payments
NPI 1588320527 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 25 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $280 |
| Lundbeck LLC | 5 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: ARISTADA, REXULTI, CAPLYTA, LYBALVI, ABILIFY ASIMTUFII, Qelbree, INGREZZA.
Industry payments across WY — which companies pay providers there.
